# DYN (Dyne Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Dyne Therapeutics, Inc. reported $1.23B in total assets and a net loss of $604.9M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DYN
- Markdown: https://convexityos.com/fundamentals/DYN.md
- SEC CIK: 0001818794
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:19 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001818794&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$620.1M | Operating profit |
| Net Income | FY 2025 | -$604.9M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.47 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$568.8M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.13B | Total debt: $218.9M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $398.3M | $281.4M | $210.8M | $142.8M | $121.3M | $45.20M | $11.04M |
| Total Operating Expenses | $468.2M | $343.9M | $242.2M | $171.0M | $150.0M | $58.65M | $13.83M |
| **Operating Income** | -$468.2M | -$343.9M | -$242.2M | -$171.0M | -$150.0M | -$58.65M | -$13.83M |
| **EBITDA** | -$466.1M | -$342.2M | -$240.5M | -$169.3M | -$148.9M | -$57.95M | -$13.55M |
| Interest Income | $29.86M | $26.92M | $7.64M | $2.92M | $742K | $56K | $290K |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- |
| **Net Income** | -$446.2M | -$317.4M | -$235.9M | -$168.1M | -$149.3M | -$59.44M | -$14.86M |
| Basic EPS | -$3.47 | -$3.37 | -$3.95 | -$3.23 | -$2.93 | -$4.13 | -$6.08 |
| **Diluted EPS** | -$3.47 | -$3.37 | -$3.95 | -$3.23 | -$2.93 | -$4.13 | -$6.08 |
| Basic Shares Outstanding | -- | -- | -- | -- | 50.9M | 14.4M | 2.4M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 50.9M | 14.4M | 2.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $161.7M | $152.2M | $100.9M | $95.43M | $97.22M | $99.24M | $106.4M | $81.81M |
| Total Operating Expenses | $197.1M | $181.7M | $125.3M | $116.1M | $113.9M | $115.8M | $122.4M | $97.11M |
| **Operating Income** | -$197.1M | -$181.7M | -$125.3M | -$116.1M | -$113.9M | -$115.8M | -$122.4M | -$97.11M |
| **EBITDA** | -$196.5M | -$181.1M | -$124.7M | -$115.6M | -$113.4M | -$115.3M | -$121.9M | -$96.66M |
| Interest Income | $9.77M | $7.79M | $8.76M | $7.66M | $8.48M | $6.62M | $7.10M | $7.59M |
| Interest Expense | -- | -- | -- | -- | $2.90M | $94K | -- | -- |
| **Net Income** | -$193.6M | -$178.6M | -$120.9M | -$112.0M | -$108.0M | -$110.9M | -$115.4M | -$89.54M |
| Basic EPS | -$1.06 | -$1.08 | -$0.73 | -- | -$0.76 | -$0.97 | -$1.05 | -- |
| **Diluted EPS** | -$1.06 | -$1.08 | -$0.73 | -- | -$0.76 | -$0.97 | -$1.05 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $893.4M | $435.4M | $121.6M | $172.1M | $200.8M | $300.9M | $14.63M |
| Short-Term Investments | $217.2M | $206.8M | $1.47M | $83.86M | $175.7M | $44.46M | $0 |
| **Cash & Short-Term Investments** | $1.11B | $642.3M | $123.1M | $256.0M | $376.6M | $345.3M | $14.63M |
| **Total Current Assets** | $1.13B | $659.3M | $129.4M | $265.6M | $382.4M | $349.1M | $14.76M |
| Property, Plant & Equipment, Net | $24.03M | $5.40M | $4.78M | $5.95M | $4.68M | $1.95M | $1.49M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $191K |
| **Total Non-Current Assets** | $31.20M | $31.95M | $35.71M | $40.73M | $43.27M | $4.25M | $1.68M |
| **Total Assets** | $1.19B | $691.2M | $165.1M | $306.3M | $425.7M | $353.3M | $16.44M |
| Accounts Payable | $8.08M | $6.56M | $22.94M | $5.26M | $4.03M | $3.44M | $1.26M |
| **Total Current Liabilities** | $50.62M | $42.26M | $51.09M | $28.09M | $28.72M | $10.97M | $2.36M |
| Long-Term Debt | $148.9M | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $164.2M | $19.14M | $22.70M | $25.87M | $28.74M | $0 | $42K |
| **Total Liabilities** | $214.8M | $61.40M | $73.79M | $53.96M | $57.47M | $10.97M | $2.40M |
| **Total Debt (incl. Leases)** | $169.2M | $23.99M | $27.41M | $30.48M | $32.64M | -- | -- |
| Common Stock | $16K | $10K | $6.0K | $6.0K | $6.0K | $5.0K | $1.0K |
| Retained Earnings | -$1.40B | -$949.9M | -$632.5M | -$396.6M | -$228.5M | -$79.18M | -$19.75M |
| Accumulated Other Comp. Income | $475K | $6.0K | $0 | -$571K | -$269K | -$27K | -- |
| **Total Stockholders' Equity** | $972.1M | $629.8M | $91.29M | $252.4M | $368.2M | $342.4M | $14.04M |
| Total Equity | $972.1M | $629.8M | $91.29M | $252.4M | $368.2M | $342.4M | $14.04M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $913.2M | $676.1M | $753.1M | $893.4M | $573.6M | $485.0M | $472.3M | $435.4M |
| Short-Term Investments | $221.2M | $222.4M | $219.1M | $217.2M | $218.3M | $198.9M | $205.2M | $206.8M |
| **Cash & Short-Term Investments** | $1.13B | $898.5M | $972.2M | $1.11B | $791.9M | $683.9M | $677.5M | $642.3M |
| **Total Current Assets** | $1.18B | $937.9M | $1.02B | $1.13B | $806.3M | $698.0M | $689.5M | $659.3M |
| Property, Plant & Equipment, Net | $7.14M | $24.56M | $23.68M | $24.03M | $23.97M | $5.67M | $5.75M | $5.40M |
| Other Non-Current Assets | $18.80M | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $58.77M | $56.12M | $58.92M | $31.20M | $60.80M | $31.04M | $31.57M | $31.95M |
| **Total Assets** | $1.23B | $994.0M | $1.08B | $1.19B | $867.1M | $729.0M | $721.1M | $691.2M |
| Accounts Payable | $14.90M | $12.15M | $10.78M | $8.08M | $12.06M | $14.02M | $7.02M | $6.56M |
| **Total Current Liabilities** | $90.55M | $78.03M | $51.25M | $50.62M | $59.85M | $41.47M | $33.88M | $42.26M |
| Long-Term Debt | $200.0M | $199.3M | $149.4M | $148.9M | $99.15M | $98.81M | -- | $0 |
| **Total Non-Current Liabilities** | $213.3M | $213.8M | $163.6M | $164.2M | $115.4M | $116.1M | $18.22M | $19.14M |
| **Total Liabilities** | $303.9M | $291.9M | $214.9M | $214.8M | $175.3M | $157.5M | $52.10M | $61.40M |
| **Total Debt (incl. Leases)** | $218.9M | $219.2M | $168.7M | $169.2M | $120.5M | $121.1M | $23.33M | $23.99M |
| Common Stock | $18K | $16K | $16K | $16K | $14K | $11K | $11K | $10K |
| Retained Earnings | -$1.89B | -$1.70B | -$1.52B | -$1.40B | -$1.28B | -$1.18B | -$1.07B | -$949.9M |
| Accumulated Other Comp. Income | -$1.00M | -$353K | -$137K | $475K | $496K | $252K | $241K | $6.0K |
| **Total Stockholders' Equity** | $930.9M | $702.2M | $865.1M | $972.1M | $691.8M | $571.4M | $669.0M | $629.8M |
| Total Equity | $930.9M | $702.2M | $865.1M | $972.1M | $691.8M | $571.4M | $669.0M | $629.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$446.2M | -$317.4M | -$235.9M | -$168.1M | -$149.3M | -$59.44M | -$14.86M |
| Depreciation & Amortization | $2.05M | $1.67M | $1.67M | $1.68M | $1.09M | $700K | $271K |
| Stock-Based Compensation | $45.85M | $45.86M | $19.97M | $15.18M | $17.54M | $6.59M | $26K |
| **Operating Cash Flow** | -$403.2M | -$292.4M | -$188.2M | -$153.6M | -$119.6M | -$46.51M | -$11.83M |
| Capital Expenditure | -$1.92M | -$2.38M | -$729K | -$3.07M | -$3.62M | -$1.16M | -$1.65M |
| **Free Cash Flow** | -$405.1M | -$294.7M | -$188.9M | -$156.7M | -$123.2M | -$47.67M | -$13.48M |
| Purchases of Investments | -$180.5M | -$317.4M | -$44.26M | -$121.2M | -$236.7M | -$44.50M | -- |
| **Investing Cash Flow** | -$28.75M | -$204.1M | $83.31M | $87.20M | -$137.9M | -$45.66M | -$1.65M |
| Common Stock Issued | $140.7M | $97.87M | $52.37M | $36.86M | -- | -- | -- |
| **Financing Cash Flow** | $890.3M | $809.9M | $54.32M | $37.39M | $157.8M | $380.7M | $19.99M |
| **Net Change in Cash** | $458.3M | $313.4M | -$50.52M | -$29.05M | -$99.63M | $288.5M | $6.51M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$193.6M | -$178.6M | -$120.9M | -$112.0M | -$108.0M | -$110.9M | -$115.4M | -$89.54M |
| Depreciation & Amortization | $600K | $600K | $550K | $521K | $500K | $500K | $502K | $450K |
| Stock-Based Compensation | $16.21M | $14.98M | $13.08M | $11.23M | $11.08M | $10.52M | $13.02M | $10.48M |
| **Operating Cash Flow** | -$177.5M | -$130.3M | -$144.9M | -$111.8M | -$90.78M | -$94.70M | -$105.9M | -$84.33M |
| Capital Expenditure | -$2.01M | -$1.51M | -$221K | -$484K | -$395K | -$60K | -$981K | -$1.07M |
| **Free Cash Flow** | -$179.5M | -$131.8M | -$145.1M | -$112.3M | -$91.17M | -$94.76M | -$106.9M | -$85.41M |
| Purchases of Investments | -$51.56M | -$42.79M | -$64.28M | -$26.71M | -$46.92M | -$40.93M | -$65.97M | -$52.71M |
| **Investing Cash Flow** | -$1.29M | -$4.79M | -$2.39M | $982K | -$37.97M | $6.77M | $1.46M | -$16.01M |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $0 | $140.7M | $0 |
| **Financing Cash Flow** | $418.1M | $58.11M | $7.06M | $431.0M | $217.3M | $100.8M | $141.2M | $3.64M |
| **Net Change in Cash** | $239.3M | -$76.97M | -$140.2M | $320.1M | $88.58M | $12.85M | $36.81M | -$96.71M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -45.9% | -50.4% | -258.4% | -66.6% | -40.5% | -17.4% | -105.9% |
| Return on Assets (ROA) | -37.6% | -45.9% | -142.9% | -54.9% | -35.1% | -16.8% | -90.4% |
| Current Ratio | 22.25x | 15.60x | 2.53x | 9.46x | 13.31x | 31.83x | 6.26x |
| Quick Ratio | 21.94x | 15.20x | 2.41x | 9.11x | 13.11x | 31.49x | 6.21x |
| Debt to Equity | 0.17x | 0.04x | 0.30x | 0.12x | 0.09x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -65.0% | -74.0% | -52.2% | -45.9% | -61.3% | -72.3% | -54.9% | -50.4% |
| Return on Assets (ROA) | -49.0% | -52.3% | -41.8% | -37.6% | -48.9% | -56.6% | -50.9% | -45.9% |
| Current Ratio | 12.99x | 12.02x | 19.92x | 22.25x | 13.47x | 16.83x | 20.35x | 15.60x |
| Quick Ratio | 12.53x | 11.51x | 18.97x | 21.94x | 13.23x | 16.49x | 20.00x | 15.20x |
| Debt to Equity | 0.24x | 0.31x | 0.19x | 0.17x | 0.17x | 0.21x | 0.03x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
